Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403286 · ClinicalTrials.gov registry record · Phase 2
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 457
- Enrollment target
NCT00403286: Completed Phase 2 study, sponsored by Dey.
NCT00403286 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 457 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (244% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00403286, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 457 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the appropriate dose of fluticasone propionate/formoterol fumarate that is closest to Advair Diskus (fluticasone propionate/salmeterol xinafoate using pulmonary function, safety, and levels of study drug in blood plasma in patients with chronic obstructive pulmonary disease.
Interventions
- DRUG Fluticasone Propionate
- DRUG Fluticasone Propionate/Formoterol Fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 457 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
What the finished NCT00403286 record still lists
NCT00403286 is an interventional study that assigns participants to a tested intervention. The registered 457 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (244% higher).
The record links to 0 conditions, and to 2 interventions - of which Fluticasone Propionate is the first listed.
NCT00403286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00403286 about?
NCT00403286 is a clinical study titled "A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease". The purpose of the study is to determine the appropriate dose of fluticasone propionate/formoterol fumarate that is closest to Advair Diskus (fluticasone propionate/salmeterol xinafoate using pulmonary function, safety, and levels of study drug in blood plasma in patients with chronic obstructive pu...
What is the current status of trial NCT00403286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 457 participants. The study started on 2006-11. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00403286?
The interventions under investigation include: Fluticasone Propionate (DRUG), Fluticasone Propionate/Formoterol Fumarate (DRUG).
Who is sponsoring clinical trial NCT00403286?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00403286's enrollment target sits among peer trials
457 84th of 2000 higher than 1,917 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05856942 · 458 participants · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT05820919 · 456 participants · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia